Do you have Vitiligo ?

Would you consider participating in a clinical research study of an investigational therapy known as afamelanotide?

Eligible patients will receive either narrowband UVB (NB-UVB) light therapy in combination with afamelanotide, or with NB-UVB alone.

If You :

  1. Have vitiligo on your face and body
  2. Have a medium to dark skin type
  3. Are aged 12+
  4. Are able to attend up to 14 clinic visits over 12 months.

Then you may be eligible to participate, and partcipants may be eligible for travel reimbursements.